259 results on '"Yarlas, Aaron"'
Search Results
2. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
3. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses
4. Construct Validity of the 10-meter Walk/Run Test to Assess Motor Impairment in Patients with Alexander Disease (P2-8.004)
5. Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review
6. Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
7. Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR
8. Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia Syndrome
9. The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine
10. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators
11. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
12. The development and validation of a revised version of the Medical Outcomes Study Sleep Scale (MOS Sleep-R)
13. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis
14. Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
15. Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review
16. Schema Modification and Enhancement as Predictors of Interest: A Test of the Knowledge-schema Theory of Cognitive Interest.
17. Learning as a Predictor of Situational Interest.
18. Are Relations Directly Detected at Initial Encoding?
19. Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
20. Problem Representation in Experts and Novices: Part 2. Underlying Processing Mechanisms
21. Problem Representation in Experts and Novices: Part 1. Differences in the Content of Representation
22. Additional file 1 of The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
23. Additional file 2 of The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
24. Additional file 3 of The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
25. Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review
26. Alternative Approaches to Causal Induction: The Probabilistic Contrast Versus the Rescorla-Wagner Model
27. S84 Systematic Literature Review of the Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators
28. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses
29. The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine
30. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
31. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
32. Commentary on "A new indicator for the measurement of change with ordinal scores"
33. Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
34. Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics and Telepsychiatry Use During COVID-19 Pandemic
35. A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain
36. The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX® formulated delayed-release mesalamine
37. Measuring the health status burden in hemodialysis patients using the SF-36 ® health survey
38. Treatment satisfaction for gene silencing pharmacotherapies for the treatment of hereditary transthyretin amyloidosis with polyneuropathy
39. Patient-reported outcomes by time from symptom onset to first evidence of pharmacotherapy among patients with transthyretin amyloidosis
40. A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression
41. Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials
42. Editorial response to Aimo et al Quality‐of‐life assessment in amyloid transthyretin amyloidosis
43. Additional file 1 of Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis
44. Additional file 2 of Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis
45. Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
46. Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEURO-TTR Study (2333)
47. Measuring the health status burden in hemodialysis patients using the SF-36® health survey
48. Treatment satisfaction for gene silencing pharmacotherapies for the treatment of hereditary transthyretin amyloidosis with polyneuropathy
49. Additional file 1 of Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
50. Additional file 2 of Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.